MedPath

effects of Probiotic Bacteria on Gastrointestinal Side Effects of the Radioiodine Therapy in Patients with Differentiated Thyroid Carcinoma

Phase 3
Recruiting
Conditions
Reduction of gastrointestinal complications due to iodine therapy of differentiated thyroid cancer.
Malignant neoplasm of thyroid gland
Registration Number
IRCT20220226054126N1
Lead Sponsor
Shiraz university of medical science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

Patients with Differentiated Thyroid Carcinoma under Radioiodine Therapy
Patients between 18-90 years old

Exclusion Criteria

Consumption of narcotic painkillers
Acute or chronic complications before starting treatment
Take any antibiotics from one week before the start of treatment until the end of the study
Use of any prebiotics and probiotics in 15 days before starting treatment
Use of anti-diarrheal drugs (unless prescribed by a doctor)
History of treatment with radioactive iodine or radiation therapy in previous years
Patient dissatisfaction
Lack of adherence to diet

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Gastrointestinal complications. Timepoint: At the beginning of the study and one month after starting bacterial probiotics. Method of measurement: Question from the patient.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath